MCID: STT004
MIFTS: 35

Steatorrhea malady

Category: Gastrointestinal diseases

Aliases & Classifications for Steatorrhea

About this section

Aliases & Descriptions for Steatorrhea:

Name: Steatorrhea 10 47 12 36
 
Fatty Stool 10

Classifications:



External Ids:

Disease Ontology10 DOID:10602
MeSH36 D045602
NCIt42 C86917
UMLS65 C0038238

Summaries for Steatorrhea

About this section
Wikipedia:68 Steatorrhea (or steatorrhoea) is the presence of excess fat in feces. Stools may be bulky and difficult... more...

MalaCards based summary: Steatorrhea, also known as fatty stool, is related to glucose intolerance and pancreatic steatorrhea. An important gene associated with Steatorrhea is PNLIP (Pancreatic Lipase), and among its related pathways are Bile secretion and Fat digestion and absorption. Affiliated tissues include bone, lung and brain, and related mouse phenotype homeostasis/metabolism.

Related Diseases for Steatorrhea

About this section

Diseases related to Steatorrhea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 254)
idRelated DiseaseScoreTop Affiliating Genes
1glucose intolerance29.4CCK, CELA1, CFTR, MTTP, PNLIP, SCT
2pancreatic steatorrhea12.4
3celiac disease11.3
4tropical sprue11.3
5bile acid malabsorption, primary10.5
6hypobetalipoproteinemia10.3
7hypomagnesemia 1, intestinal10.3
8blind loop syndrome10.3
9glucose-6-phosphate translocase deficiency10.3SCT, SST
10cholesterol ester storage disease10.3SCT, SST
11senile angioma10.3SCT, SST
12inhibited male orgasm10.2SCT, SST
13ampulla of vater neoplasm10.2SCT, SST
14leukemia10.2
15lymphoma10.2
16intraorbital meningioma10.2CCK, SCT
17secondary progressive multiple sclerosis10.2SCT, SST
18distal myopathy with posterior leg and anterior hand involvement10.2CFTR, SCT
19duodenal disease10.2CCK, SCT
20malignant spiradenoma10.2CCK, SCT
21lung giant cell carcinoma10.2SCT, SST
22colorectal cancer10.2
23retinitis10.2
24gastric gastrinoma10.2SCT, SST
25polyglucosan body disease, adult form10.2CCK, SCT
26biliary tract disease10.2CCK, SST
27sm-ahnmd10.2CCK, SCT
28osmotic diarrhea10.1CFTR, SST
29hepatocellular carcinoma10.1
30sarcoma10.1
31goiter10.1
32aortic aneurysm10.1
33adenoma10.1
34thyroiditis10.1
35aneurysm10.1
36endotheliitis10.1
37bladder lateral wall cancer10.1CCK, SST
38rasmussen johnsen thomsen syndrome10.1CCK, SST
39steroid inherited metabolic disorder10.1SCT, SST
40infiltrating bladder lymphoepithelioma-like carcinoma10.1CCK, SST
41meningitis and encephalitis10.0CCK, SST
42pancreatitis10.0CCK, CFTR
43myocardial infarction10.0
44lung cancer10.0
45prostate cancer10.0
46breast cancer10.0
47hodgkin lymphoma10.0
48renal cell carcinoma10.0
49ischemic optic neuropathy10.0
50short bowel syndrome10.0

Graphical network of the top 20 diseases related to Steatorrhea:



Diseases related to steatorrhea

Symptoms for Steatorrhea

About this section

Drugs & Therapeutics for Steatorrhea

About this section

Drugs for Steatorrhea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PancrelipaseapprovedPhase 4, Phase 3, Phase 2, Phase 188053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
Creon
PA
Pancreatic alpha-amylase precursor
Pancreaze
 
Pancrelipase
Pertzye
Polocaine-mpf
Ultresa
Viokace
Zenpep
2pancreatinPhase 4, Phase 3, Phase 2, Phase 1880
3Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Phase 16401
4
Omeprazoleapproved, investigationalPhase 332173590-58-64594
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(S)-(-)-Omeprazole
(S)-Omeprazole
119141-89-8
131959-78-9
172964-80-6
2,3,5-Trimethylpyridine/Omeprazole
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Aulcer
Axagon
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Being Well Omeprazole
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CPD000058847
Care One Omeprazole
Ceprandal
D00455
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dg Health Omeprazole
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Equaline Omeprazole
Equate Omeprazole Delayed Release acid reducer
Erbolin
Esomeprazole
Esomperazole
Esopral
Exchange Select Omeprazole
Exter
Family Wellness Omeprazole
Formu Care Omeprazole
Fulton Street Market Omeprazole
Gasec
Gastrimut
Gastroloc
Gibancer
Good Neighbor Pharmacy Omeprazole
Good Sense Omeprazole
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
Harmon Face Values Omeprazole
Health Mart Omeprazole
Healthy Accents Omeprazole
I06-0705
IDI1_032523
Indurgan
Inhibitron
Inhipump
Kirkland Signature Omeprazole
LS-7629
Leader Omeprazole
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Members Mark Omeprazole
Mepral
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
Mopral
 
Morecon
NCGC00016925-01
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMP
OMZ
Ocid
Olex
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole (JAN/USP/INN)
Omeprazole Delayed Release
Omeprazole Delayed-release
Omeprazole Magnesium
Omeprazole Pellets
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazole sodium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesec
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Prazentol
Prazidec
Prazolit
Preferred Plus Omeprazole
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Quality Choice Omeprazole
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
Shoprite Omeprazole
Simply Right Omeprazole
Smart Sense Omeprazole
Sunmark Omeprazole
TL8005099
Tedec Ulceral
Topcare Omeprazole
UNII-KG60484QX9
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
omeprazole
5
Proton pump inhibitorsPhase 3958
Synonyms:
 
PPIs
6AntacidsPhase 31453
7Anti-Ulcer AgentsPhase 31453
8Pharmaceutical SolutionsPhase 2, Phase 37004
9
Nicotineapproved97354-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+-)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(R,S)-nicotine
(RS)-nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(±)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
American Fare Nicotine Transdermal System
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Careone Nicotine Transdermal System Step 1
Careone Nicotine Transdermal System Step 2
Careone Nicotine Transdermal System Step 3
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Equaline Nicotine Transdermal System STEP 1
Exchange Select Nicotine Transdermal System STEP 3
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
Habitrol Patch Nicotine Transdermal System, Step 1
Habitrol Patch Nicotine Transdermal System, Step 2
Habitrol Patch Nicotine Transdermal System, Step 3
Healthmart Nicotine Transdermal System STEP 1
Healthmart Nicotine Transdermal System STEP 2
Healthmart Nicotine Transdermal System STEP 3
Kroger Nicotine Transdermal System STEP 1
Kroger Nicotine Transdermal System STEP 2
Kroger Nicotine Transdermal System STEP 3
L(-)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
LS-202
Leader Nicotine
Leader Nicotine Transdermal System STEP 1
Leader Nicotine Transdermal System STEP 2
Leader Nicotine Transdermal System STEP 3
MLS001055457
 
MLS001335905
Mach-Nic
Meijer Nicotine Transdermal System STEP 2
Meijer Nicotine Transdermal System Step 1
Meijer Nicotine Transdermal System Step 3
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm CQ
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine TRANSDERMAL SYSTEM
Nicotine Transdermal System PATCH KIT
Nicotine Transdermal System STEP 1
Nicotine Transdermal System STEP 2
Nicotine Transdermal System STEP 3
Nicotine Transdermal System Step 1
Nicotine Transdermal System Step 2
Nicotine Transdermal System Step 3
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotine transdermal system
Nicotrol
Nicotrol (professional Sample)
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
Rite Aid Nicotine Transdermal System Step 1
Rite Aid Nicotine Transdermal System Step 2
Rite Aid Nicotine Transdermal System Step 3
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Safeway Nicotine Transdermal System STEP 1
Safeway Nicotine Transdermal System STEP 2
Safeway Nicotine Transdermal System STEP 3
Smart Sense Nicotine
Sunmark Nicotine
Sunmark Nicotine Transdermal System STEP 1
Sunmark Nicotine Transdermal System STEP 2
Sunmark Nicotine Transdermal System STEP 3
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
10
Teriparatideapproved, investigational12952232-67-416133850
Synonyms:
52232-67-4
D06078
Forteo
 
Forteo (TN)
TERIPARATIDE
Teriparatide (USAN/INN)
Teriparatide (genetical recombination)
Teriparatide (genetical recombination) (JAN)
11vitamin d1524
12Vitamins3857
13glucocorticoids3896
14Calcium, Dietary4678
15Antibodies4477
16Immunoglobulins4477
17Bone Density Conservation Agents2600
18Bile Acids and Salts86

Interventional clinical trials:

(show all 25)
idNameStatusNCT IDPhase
1Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyCompletedNCT01327703Phase 4
2Malabsorption Blood Test:Toward a Novel Approach to Quantify SteatorrheaCompletedNCT00572975Phase 4
3Enzyme Suppletion in Exocrine Pancreatic DysfunctionCompletedNCT01430234Phase 4
4Pancreatic Enzyme Suppletion in Pancreatic CancerWithdrawnNCT01401387Phase 4
5Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)CompletedNCT00880100Phase 3
6Safety and Efficacy Study of Viokase® 16 for the Correction of SteatorrheaCompletedNCT00559364Phase 3
7Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic FibrosisCompletedNCT00432861Phase 3
8A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic InsufficiencyCompletedNCT00662675Phase 3
9Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)CompletedNCT00513682Phase 3
10Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)CompletedNCT00408317Phase 3
11Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantationRecruitingNCT01967888Phase 2, Phase 3
12Creon in HIV Patients With SteatorrheaTerminatedNCT00623025Phase 3
13Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two DrugsWithdrawnNCT01228643Phase 3
14An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat MalabsorptionCompletedNCT00217204Phase 2
15Tolerance and Digestibility of a New Formula in Healthy InfantsCompletedNCT01184378Phase 2
16An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)CompletedNCT00559052Phase 2
17A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)CompletedNCT00676702Phase 1
18Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic FibrosisCompletedNCT00006063
19Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic PancreatitisCompletedNCT02781987
20Horton & Maizy Pilot Study for Resistant to StarchCompletedNCT01338571
21Timing of Surgical Intervention After Percutaneous Catheter Drainage in STEP UP Approach for Severe Acute PancreatitisCompletedNCT01527084
22The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms"RecruitingNCT02121626
23Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.RecruitingNCT02242123
24Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium DisordersRecruitingNCT02252679
25Comparison of Feasibility Between Internal and External Pancreatic Drainage in PancreaticoduodenectomyActive, not recruitingNCT01023594

Search NIH Clinical Center for Steatorrhea


Cochrane evidence based reviews: steatorrhea

Genetic Tests for Steatorrhea

About this section

Anatomical Context for Steatorrhea

About this section

MalaCards organs/tissues related to Steatorrhea:

33
Bone, Lung, Brain, Breast, Testes, T cells, Pancreatic islet

Animal Models for Steatorrhea or affiliated genes

About this section

MGI Mouse Phenotypes related to Steatorrhea:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053766.8CCK, CFTR, MTTP, PNLIP, SLC10A2, SST

Publications for Steatorrhea

About this section

Articles related to Steatorrhea:

(show top 50)    (show all 311)
idTitleAuthorsYear
1
MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin. (25537511)
2015
2
Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. (23798680)
2013
3
Ischaemic hepatitis precipitated by recurrent episodes of atrial fibrillation. (24433649)
2013
4
Polymorphisms: Genetic variations associated with irritable bowel syndrome. (24206546)
2013
5
Selected topics of the 4th International Cooperative Study Group meeting on immune thrombocytopenia revisited. (23664513)
2013
6
NF-I_B and CREB are required for angiotensin II type 1 receptor upregulation in neurons. (24244341)
2013
7
D category IV: a group of clinically relevant and phylogenetically diverse partial D. (23461862)
2013
8
Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia. (23100569)
2013
9
Coexistence of internal carotid artery stenosis with intracranial aneurysm. (23981434)
2013
10
Treatment of severe cold contact urticaria with omalizumab: case reports. (23341807)
2012
11
Prevention of graft-versus-host disease. (23187772)
2012
12
Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy. (23166088)
2012
13
Molecular genetics in myelodysplastic syndromes. (22986016)
2012
14
Expression of integrin-linked kinase in human hypertrophic scar and its relationship with angiogenesis]. (22340785)
2011
15
Randomized prospective evaluation of injection techniques for the treatment of lateral epicondylitis. (22049950)
2011
16
Neuroleptic malignant syndrome controversies revisited--what is the incidence of neuroleptic malignant syndrome? (21702071)
2011
17
Genomics and proteomics of pulmonary vascular disease. (23737182)
2011
18
Detection of low-level EGFR T790M mutation in lung cancer tissues. (21635547)
2011
19
Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. (22005305)
2011
20
Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. (19757173)
2010
21
Invasive neuroendocrine tumor of the kidney: a case report. (21139916)
2009
22
Lip cancer in Western Australia, 1982-2006: a 25-year retrospective epidemiological study. (19473154)
2009
23
Hypercalcemia in a patient with cholangiocarcinoma: a case report. (19878543)
2009
24
Growth hormone receptor polymorphisms. (17986824)
2007
25
Modulation of the systemic inflammatory response by recombinant human interleukin-11: a prospective randomized placebo controlled clinical study in patients with hematological malignancy. (16644288)
2006
26
Characterization of a de novo balanced 1;Y translocation in a phenotypically normal twin male infant. (16580398)
2006
27
Clinical studies with targeted toxins in malignant glioma. (18473963)
2006
28
Isolated Rosai Dorfman disease of the central nervous system presenting as dural-based and intraparenchymal lesions. (15943162)
2005
29
The E-Z(easy) clamp--a new instrument to facilitate medial ectropion repair. (16191798)
2005
30
Adult epiglottitis: a five-year retrospective chart review in a major urban centre. (17355704)
2005
31
Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties. (12663780)
2003
32
Audiological assessment in Ramsay Hunt syndrome. (11800372)
2002
33
beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. (12398896)
2002
34
TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients. (10773851)
2000
35
Deletions of 9p and the quest for a conserved mechanism of sex determination. (11001833)
2000
36
The genomic structure, chromosome location, and analysis of the human DKK1 head inducer gene as a candidate for holoprosencephaly. (10965128)
2000
37
Hypereosinophilic syndrome in acute lymphoblastic leukaemia--case report and literature review. (10859020)
2000
38
Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis. (9683785)
1998
39
Characterization of two mutations associated with epimerase- deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase. (9326324)
1997
40
Dihydrofolate reductase synthesis in the presence of immobilized methotrexate. An approach to a continuous cell-free protein synthesis system. (9174938)
1996
41
Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome? (7669625)
1995
42
Complement and IgG subclasses in agammaglobulinemic patients. (7710760)
1995
43
Fetal intestinal and renal origins of trehalase activity in human amniotic fluid. (8222277)
1993
44
Growth of certain myeloid leukemic cells can be stimulated by interleukin-2. (1777232)
1991
45
Addison's disease. (2008821)
1991
46
Meningococcal infection: evidence for school transmission. (1753114)
1991
47
Selective suppression of lymphokine production by human hybridoma suppressor factor (HSF). (2125575)
1990
48
Adenomatoid tumor of the tunica vaginalis. (13062417)
1953
49
50

Variations for Steatorrhea

About this section

Expression for genes affiliated with Steatorrhea

About this section
Search GEO for disease gene expression data for Steatorrhea.

Pathways for genes affiliated with Steatorrhea

About this section

Pathways related to Steatorrhea according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6CFTR, SLC10A2
29.5MTTP, PNLIP

GO Terms for genes affiliated with Steatorrhea

About this section

Cellular components related to Steatorrhea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055769.2CCK, SCT, SST

Sources for Steatorrhea

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet